Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Legend Biotech Corporation Sponsored ADR (LEGN) had Weighted-Average Shares Outstanding (Diluted) of 193.80M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$387.50M |
|
$33.20M |
|
$137.40M |
|
$250.10M |
|
$331.80M |
|
$55.70M |
|
$-0.20M |
|
$55.50M |
|
$55.50M |
|
$33.20M |
|
$33.20M |
|
$33.20M |
|
$33.20M |
|
$55.70M |
|
$67.40M |
|
187.00M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
193.80M |
$0.18 |
|
$0.18 |
|
| Balance Sheet Financials | |
$1.23B |
|
$125.90M |
|
$523.50M |
|
$1.75B |
|
$403.60M |
|
-- |
|
$117.70M |
|
$521.30M |
|
$1.23B |
|
$1.23B |
|
$1.23B |
|
193.77M |
|
| Cash Flow Statement Financials | |
$-106.00M |
|
$-288.00M |
|
$166.50M |
|
$901.90M |
|
$672.90M |
|
$-229.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.04 |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
64.54% |
|
14.37% |
|
14.37% |
|
-- |
|
14.32% |
|
8.57% |
|
$-121.00M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
3.31 |
|
-- |
|
-- |
|
2.70% |
|
2.70% |
|
1.90% |
|
2.70% |
|
$6.35 |
|
$-0.62 |
|
$-0.55 |
|